Voloridge Investment Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $673K | Buy |
+274,875
| New | +$673K | ﹤0.01% | 1056 |
|
|
2023
Q4 | – | Sell |
-11,269
| Closed | -$231K | – | 1413 |
|
|
2023
Q3 | $231K | Buy |
+11,269
| New | +$231K | ﹤0.01% | 1310 |
|
|
2022
Q4 | – | Sell |
-184,455
| Closed | -$2.94M | – | 1604 |
|
|
2022
Q3 | $2.94M | Sell |
184,455
-52,012
| -22% | -$830K | 0.02% | 853 |
|
|
2022
Q2 | $3.25M | Buy |
236,467
+18,360
| +8% | +$253K | 0.02% | 840 |
|
|
2022
Q1 | $3.46M | Buy |
218,107
+163,736
| +301% | +$2.6M | 0.02% | 769 |
|
|
2021
Q4 | $1.19M | Buy |
+54,371
| New | +$1.19M | 0.01% | 1230 |
|
|
2021
Q1 | – | Sell |
-45,448
| Closed | -$2.49M | – | 1614 |
|
|
2020
Q4 | $2.49M | Buy |
+45,448
| New | +$2.49M | 0.02% | 659 |
|
|
2020
Q2 | – | Sell |
-13,811
| Closed | -$193K | – | 1458 |
|
|
2020
Q1 | $193K | Buy |
+13,811
| New | +$193K | 0.01% | 964 |
|